Otis Appoints Dr. Tim Miller as Director

February 25, 2016

Vancouver, B.C. – Otis Gold Corp. (“Otis” or “the Company”) is pleased to announce that Dr. Tim Miller has joined the Company as a Director.  Dr. Miller has enjoyed a long and distinguished career in progressively senior roles with Standard Life Assurance Company, Wang UK Limited, Glaxo Wellcome plc and, most recently, with Standard Chartered Bank plc. 

During his tenure with Standard Chartered Bank plc, his roles included Chairman, Standard Chartered Bank Korea and Director level roles in the areas of corporate governance and human resources.  As Director, Property, Research and Assurance, he was a Member of the Group Management Committee and had functional responsibility for over 3,000 employees in a role that reported to the Group Chief Executive.  The position included responsibility for the Human Resources, Corporate Real Estate, Corporate Secretariat, Legal, Compliance and Assurance (including Regulatory Risk), Internal Audit and Economist/Global Research Group-wide functions.

States Otis President and CEO Craig Lindsay: “We are very pleased to welcome Dr. Miller to our Board of Directors.  In an increasingly complex regulatory and operating environment, his broad range of corporate governance experience will be of significant benefit to the Company.”

Dr. Miller has a DBA from the Nottingham University Business School, an MBA from the Scottish Business School and an M.Litt and BA from the University of Stirling.  In 2009 he was awarded a Companion of the Chartered Institute of Personnel and Development (“CIPD”) designation.

About the Company

Otis is a resource company focused on the acquisition, exploration, and development of precious metal deposits in Idaho, USA. Otis is currently developing its flagship property, the Kilgore Gold Project, located in Clark County, Idaho.


“Craig T. Lindsay”

President & CEO

For additional information, please contact:

Craig Lindsay
Tel: (604) 683-2507

Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the  TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This News Release does not constitute an offer to sell or a solicitation of an offer to sell any securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “US Securities Act”) or any State securities laws, and may not be offered or sold within the United States or to US Persons unless registered under the US Securities Act and applicable State securities laws, or an exemption from such registration is available.